Insider Transactions in Q4 2025 at Amicus Therapeutics, Inc. (FOLD)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 26
2025
|
Ellen Rosenberg Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
23,621
-4.45%
|
$236,210
$10.0 P/Share
|
|
Nov 26
2025
|
Ellen Rosenberg Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,621
+4.26%
|
$118,105
$5.13 P/Share
|
|
Nov 25
2025
|
Ellen Rosenberg Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
36,000
-6.62%
|
$360,000
$10.0 P/Share
|
|
Nov 25
2025
|
Ellen Rosenberg Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36,000
+6.21%
|
$180,000
$5.13 P/Share
|
|
Nov 24
2025
|
Ellen Rosenberg Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
36,000
-6.62%
|
$360,000
$10.06 P/Share
|
|
Nov 24
2025
|
Ellen Rosenberg Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36,000
+3.23%
|
$180,000
$5.62 P/Share
|
|
Nov 24
2025
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
14,587
-1.27%
|
$145,870
$10.04 P/Share
|
|
Nov 24
2025
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,587
+1.25%
|
$131,283
$9.03 P/Share
|
|
Nov 24
2025
|
David Michael Clark Chief People Officer |
SELL
Open market or private sale
|
Direct |
25,643
-7.95%
|
$256,430
$10.1 P/Share
|
|
Nov 24
2025
|
Jeff Castelli Chief Development Officer |
SELL
Open market or private sale
|
Direct |
76,158
-14.77%
|
$761,580
$10.16 P/Share
|
|
Nov 24
2025
|
Jeff Castelli Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+8.84%
|
$450,000
$9.03 P/Share
|
|
Nov 04
2025
|
David Michael Clark Chief People Officer |
SELL
Open market or private sale
|
Direct |
25,643
-7.36%
|
$230,787
$9.51 P/Share
|